Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Triamdocaine
- Development stage
- Unknown
- Lead developer
- RAM Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Topical, Oral
01
Overview
Triamdocaine is an investigational, first-in-class topical dry-powder therapy developed by RAM Pharmaceuticals for the treatment and prevention of severe oral mucositis (SOM) in cancer patients undergoing radiation and chemotherapy. Formulated for topical oral delivery, the drug is designed to reduce the incidence and severity of painful oral lesions, commonly referred to as "Cancer Mouth," thereby helping patients maintain their quality of life and adhere to their cancer treatment regimens. Triamdocaine has received FDA Investigational New Drug (IND) approval and is currently in Phase 2 clinical development. The product is part of RAM Pharmaceuticals' Cancer Comfort Care Initiative and is protected by U.S. patents extending through 2039.
- Brand names
- Triamdocaine
02
Targets
GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on Triamdocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Triamdocaine.